![Strategies to improve allogeneic CAR T cells. (A) Elimination of the... | Download Scientific Diagram Strategies to improve allogeneic CAR T cells. (A) Elimination of the... | Download Scientific Diagram](https://www.researchgate.net/publication/348360789/figure/fig1/AS:984585047388170@1611754776953/Strategies-to-improve-allogeneic-CAR-T-cells-A-Elimination-of-the-ab-TCR-by-knockout_Q640.jpg)
Strategies to improve allogeneic CAR T cells. (A) Elimination of the... | Download Scientific Diagram
![The role of CD52 cells in the allogeneic mixed lymphocyte reaction. (A)... | Download Scientific Diagram The role of CD52 cells in the allogeneic mixed lymphocyte reaction. (A)... | Download Scientific Diagram](https://www.researchgate.net/profile/Jonathan-Salisbury/publication/11210171/figure/fig2/AS:601761354100736@1520482495035/The-role-of-CD52-cells-in-the-allogeneic-mixed-lymphocyte-reaction-A-The-effect-of_Q640.jpg)
The role of CD52 cells in the allogeneic mixed lymphocyte reaction. (A)... | Download Scientific Diagram
![CD52/GPI− T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ... CD52/GPI− T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...](https://www.astctjournal.org/cms/attachment/52cedcdd-e971-4b73-9a4d-81b4a7624d4a/fx1_lrg.jpg)
CD52/GPI− T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...
![CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells | Cellular & Molecular Immunology CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells | Cellular & Molecular Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fcmi.2013.38/MediaObjects/41423_2013_Article_BFcmi201338_Fig1_HTML.jpg)
CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells | Cellular & Molecular Immunology
![Functional and antitumor properties of TCR/CD52-de fi cient T cells... | Download Scientific Diagram Functional and antitumor properties of TCR/CD52-de fi cient T cells... | Download Scientific Diagram](https://www.researchgate.net/publication/280117995/figure/fig3/AS:323913650327554@1454238440644/Functional-and-antitumor-properties-of-TCR-CD52-de-fi-cient-T-cells-endowed-with-CD19.png)
Functional and antitumor properties of TCR/CD52-de fi cient T cells... | Download Scientific Diagram
![Analysis of normal peripheral blood DCs for the expression of CD52 and... | Download Scientific Diagram Analysis of normal peripheral blood DCs for the expression of CD52 and... | Download Scientific Diagram](https://www.researchgate.net/profile/Jonathan-Salisbury/publication/11210171/figure/fig1/AS:601761349910548@1520482494965/Analysis-of-normal-peripheral-blood-DCs-for-the-expression-of-CD52-and-either-CD11c-or_Q640.jpg)
Analysis of normal peripheral blood DCs for the expression of CD52 and... | Download Scientific Diagram
![Frontiers | Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase Frontiers | Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase](https://www.frontiersin.org/files/Articles/792465/fimmu-12-792465-HTML/image_m/fimmu-12-792465-g001.jpg)
Frontiers | Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase
Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis | PLOS ONE
CD52 Antibody, anti-human, REAfinity™ | Recombinant antibodies | MACS Antibodies | Products | Miltenyi Biotec | USA
Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity | PLOS ONE
![The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels - ScienceDirect The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572817304575-fx1.jpg)
The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels - ScienceDirect
![Impacts on T cells via membrane CD52 and soluble CD52. Costimulation of... | Download Scientific Diagram Impacts on T cells via membrane CD52 and soluble CD52. Costimulation of... | Download Scientific Diagram](https://www.researchgate.net/publication/314651225/figure/fig1/AS:959994862239779@1605892019730/Impacts-on-T-cells-via-membrane-CD52-and-soluble-CD52-Costimulation-of-CD4-T-cells-with.gif)
Impacts on T cells via membrane CD52 and soluble CD52. Costimulation of... | Download Scientific Diagram
![Frontiers | CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer Frontiers | CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer](https://www.frontiersin.org/files/Articles/578002/fgene-11-578002-HTML/image_m/fgene-11-578002-g002.jpg)